KATIE LEE: Open Payments
NPI 1346859980 · MIDDLETOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 79 payments from 16 companies in 2025. Trend: 2023 $762 · 2024 $171 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $317 |
| Novo Nordisk Inc | 15 | $228 |
| PFIZER INC. | 11 | $154 |
| ABIOMED | 1 | $129 |
| Aadi Bioscience, Inc. | 1 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Amgen Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $55 |
Products named: VRAYLAR, Fyarro, QULIPTA, Ozempic, Wegovy, NURTEC ODT, EVENITY, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
